162 related articles for article (PubMed ID: 24489692)
1. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta-analysis of 10846 cases and 11723 controls.
Bu T; Liu L; Sun Y; Zhao L; Peng Y; Zhou S; Li L; Chen S; Gao Y
PLoS One; 2014; 9(1):e86086. PubMed ID: 24489692
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Link between XRCC1 Arg399Gln Polymorphism and Breast Cancer: a Meta-Analysis in a Single Ethnic Group.
Chen XP; Wen HF; Zhang F; Xu WH; Ma ZC; Fu SM
Clin Lab; 2017 Apr; 63(4):725-731. PubMed ID: 28397459
[TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
4. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
5. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
6. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
[TBL] [Abstract][Full Text] [Related]
7. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
[TBL] [Abstract][Full Text] [Related]
8. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
10. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
11. Association between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Cervical Cancer Risk: A Meta-Analysis in the Chinese Population.
Zhang F; Li B; Wu HY; Shang LX
Gynecol Obstet Invest; 2017; 82(4):382-387. PubMed ID: 27487002
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
Zhu W; Yao J; Li Y; Xu B
Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108
[TBL] [Abstract][Full Text] [Related]
14. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
[TBL] [Abstract][Full Text] [Related]
17. Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
Forat-Yazdi M; Gholi-Nataj M; Neamatzadeh H; Nourbakhsh P; Shaker-Ardakani H
Asian Pac J Cancer Prev; 2015; 16(8):3285-91. PubMed ID: 25921133
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
Geng J; Zhang YW; Huang GC; Chen LB
World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980
[TBL] [Abstract][Full Text] [Related]
20. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
